Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Functional role of TRP channels in modulating ER stress and Autophagy.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Physiotherapy as an immunoactive therapy? A pilot study.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Multiple sclerosis: An old drug plays a new trick.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
CCSVI and MS: no meaning, no fact.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.

Pages